Syngen Biotech Co.,Ltd. (8279.TWO)

150.00 -1.00 (-0.66%) At close: 11:31AM CST

Syngen Biotech Co.,Ltd.

Building A
No.154, Kaiyuan Road Xinying District
Tainan City 73055
Taiwan
886 6 632 3588
https://www.syngen.com.tw

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Wei Ren Chen	Chairman of the Board and President	N/A	N/A	N/A
Zhi Ming Huang	Finance Manager and Director	N/A	N/A	N/A
Zihui Wang	Accounting Supervisor	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.

Description

Syngen Biotech Co.,Ltd. engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicine. It also offers contract manufacturing; science-based and bio active pharmaceutical ingredients; and private labelling. In addition, the company provides organic food OEM/ODM, explosion proof extraction, brand agency, and wholesale distribution services. The company was founded in 1988 and is based in Tainan City, Taiwan.

Corporate governance

Syngen Biotech Co.,Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.